These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10950092)

  • 1. High biotinidase activity in type Ia glycogen storage disease.
    Saltik IN; Ozen H; Koçak N; Yüce A; Gürakan F
    Am J Gastroenterol; 2000 Aug; 95(8):2144. PubMed ID: 10950092
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased plasma biotinidase activity in patients with glycogen storage disease type Ia: effect of biotin supplementation.
    Burlina AB; Dermikol M; Mantau A; Piovan S; Grazian L; Zacchello F; Shin Y
    J Inherit Metab Dis; 1996; 19(2):209-12. PubMed ID: 8739967
    [No Abstract]   [Full Text] [Related]  

  • 3. Markedly elevated serum biotinidase activity may indicate glycogen storage disease type Ia.
    Wolf B; Freehauf CL; Thomas JA; Gordon PL; Greene CL; Ward JC
    J Inherit Metab Dis; 2003; 26(8):805-9. PubMed ID: 14739685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects and enzymologic diagnosis of glycogenosis type 1].
    Bührdel P; Zimmermann G; Theile H; Braun W; Beyreiss K
    Kinderarztl Prax; 1977 May; 45(5):211-8. PubMed ID: 267792
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.
    Nguyen AD; Pan CJ; Weinstein DA; Chou JY
    Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotinidase activity in patients with phenylketonuria.
    Schulpis KH; Papakonstantinou E; Kalogirou S
    J Inherit Metab Dis; 1995; 18(6):750-1. PubMed ID: 8750615
    [No Abstract]   [Full Text] [Related]  

  • 8. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
    Koeberl DD; Sun BD; Damodaran TV; Brown T; Millington DS; Benjamin DK; Bird A; Schneider A; Hillman S; Jackson M; Beaty RM; Chen YT
    Gene Ther; 2006 Sep; 13(17):1281-9. PubMed ID: 16672983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic heterogeneity of glycogen storage disease type Ia in France: a study of 48 patients.
    Trioche P; Francoual J; Chalas J; Capel L; Lindenbaum A; Odièvre M; Labrune P
    Hum Mutat; 2000 Nov; 16(5):444. PubMed ID: 11058903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen storage disease type Ia: molecular study in Brazilian patients.
    de C Reis F; Caldas HC; Norato DY; Schwartz IV; Giugliani R; Burin MG; Sartorato EL
    J Hum Genet; 2001; 46(3):146-9. PubMed ID: 11310582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel missense mutation (H119L) identified in a Taiwan Chinese family with glycogen storage disease Ia (Von Gierke disease).
    Wu MC; Tsai FJ; Lee CC; Tsai CH; Wu JY
    Hum Mutat; 2000 Nov; 16(5):447. PubMed ID: 11058910
    [No Abstract]   [Full Text] [Related]  

  • 12. Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency.
    Wolf B; Spencer R; Gleason T
    J Pediatr; 2002 Feb; 140(2):242-6. PubMed ID: 11865279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial functioning in youth with glycogen storage disease type I.
    Storch E; Keeley M; Merlo L; Jacob M; Correia C; Weinstein D
    J Pediatr Psychol; 2008 Aug; 33(7):728-38. PubMed ID: 18296725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biotinidase deficiency. Its form of presentation and response to treatment].
    Campistol J; Vilaseca MA; Ribes A; Riudor E
    An Esp Pediatr; 1996 Apr; 44(4):389-92. PubMed ID: 8796946
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer.
    Ghosh A; Allamarvdasht M; Pan CJ; Sun MS; Mansfield BC; Byrne BJ; Chou JY
    Gene Ther; 2006 Feb; 13(4):321-9. PubMed ID: 16195703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coffin-Siris syndrome with normal plasma biotinidase activity.
    Bonneau D; Berthier M; Oriot D; Munnich A
    Eur J Pediatr; 1991 Jul; 150(9):687. PubMed ID: 1915529
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
    Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel nonsense mutation (Q24X) in the glucose-6-phosphatase gene of a Portuguese patient with GSD Ia (von Gierke disease).
    Rocha H; Cabral A; Vilarinho L
    Hum Mutat; 2000 Nov; 16(5):449. PubMed ID: 11058918
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycogen storage diseases in Thai patients: Phramongkutklao Hospital experience.
    Kamolsilp M
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S295-301. PubMed ID: 16858972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenatal diagnosis of glycogen storage disease Ia by screening for hot spot mutations in combination with the 1176 nucleotide polymorphism linkage analysis].
    Qiu WJ; Zhang YF; Pan J; Ye J; Liu XQ; Han LS; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):44-8. PubMed ID: 15696478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.